ATE423093T1 - Neue mao-b-hemmer - Google Patents
Neue mao-b-hemmerInfo
- Publication number
- ATE423093T1 ATE423093T1 AT05761873T AT05761873T ATE423093T1 AT E423093 T1 ATE423093 T1 AT E423093T1 AT 05761873 T AT05761873 T AT 05761873T AT 05761873 T AT05761873 T AT 05761873T AT E423093 T1 ATE423093 T1 AT E423093T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- compounds
- inhibitors
- relates
- new mao
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/12—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
- C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04102907 | 2004-06-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE423093T1 true ATE423093T1 (de) | 2009-03-15 |
Family
ID=35285525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05761873T ATE423093T1 (de) | 2004-06-23 | 2005-06-15 | Neue mao-b-hemmer |
Country Status (15)
Country | Link |
---|---|
US (1) | US7253318B2 (de) |
EP (1) | EP1761480B1 (de) |
JP (1) | JP4427578B2 (de) |
KR (1) | KR100855618B1 (de) |
CN (1) | CN100554244C (de) |
AT (1) | ATE423093T1 (de) |
AU (1) | AU2005256395B2 (de) |
BR (1) | BRPI0512404A (de) |
CA (1) | CA2571505A1 (de) |
DE (1) | DE602005012826D1 (de) |
ES (1) | ES2319213T3 (de) |
MX (1) | MXPA06014902A (de) |
PL (1) | PL1761480T3 (de) |
RU (1) | RU2392267C2 (de) |
WO (1) | WO2006000324A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130046093A1 (en) * | 2011-08-18 | 2013-02-21 | Korea Institute Of Science And Technology | Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same |
CA2922190A1 (en) * | 2013-08-30 | 2015-03-05 | The University Of British Columbia | Mao-b selective inhibitor compounds, pharmaceutical compositions thereof and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5832859A (ja) * | 1981-08-20 | 1983-02-25 | Dainippon Pharmaceut Co Ltd | N,n−ジメチルカルバミン酸ベンジルエステル誘導体 |
US4777280A (en) * | 1986-07-01 | 1988-10-11 | University Patents, Inc. | Phenylbenzoate 1-cyanoalkoxy compounds |
US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
JP3258027B2 (ja) | 1996-03-15 | 2002-02-18 | サマーセット・ファーマシューティカルズ・インコーポレイテッド | セレジリン投与による末梢ニューロパシーの予防および治療方法 |
JPH1147881A (ja) | 1997-08-05 | 1999-02-23 | Daido Steel Co Ltd | 精密鋳造用簡易型の製造方法 |
JPH11147881A (ja) * | 1997-08-21 | 1999-06-02 | Sankyo Co Ltd | ジヒドロベンゾキノン骨格を有する除草性アゾール誘導体 |
JPH11302235A (ja) * | 1998-04-15 | 1999-11-02 | Taisho Pharmaceut Co Ltd | フェノキシアルキルアミン誘導体 |
AU1359801A (en) | 1999-11-05 | 2001-06-06 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
KR20050088992A (ko) * | 2002-10-07 | 2005-09-07 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 아난드아미드 가수분해 차단을 통한 불안감의 조절 |
-
2005
- 2005-06-15 EP EP05761873A patent/EP1761480B1/de not_active Not-in-force
- 2005-06-15 AT AT05761873T patent/ATE423093T1/de not_active IP Right Cessation
- 2005-06-15 ES ES05761873T patent/ES2319213T3/es active Active
- 2005-06-15 PL PL05761873T patent/PL1761480T3/pl unknown
- 2005-06-15 JP JP2007517146A patent/JP4427578B2/ja not_active Expired - Fee Related
- 2005-06-15 CN CNB2005800210329A patent/CN100554244C/zh not_active Expired - Fee Related
- 2005-06-15 WO PCT/EP2005/006398 patent/WO2006000324A2/en active Application Filing
- 2005-06-15 KR KR1020067026984A patent/KR100855618B1/ko not_active IP Right Cessation
- 2005-06-15 RU RU2006143570/04A patent/RU2392267C2/ru not_active IP Right Cessation
- 2005-06-15 DE DE602005012826T patent/DE602005012826D1/de active Active
- 2005-06-15 AU AU2005256395A patent/AU2005256395B2/en not_active Ceased
- 2005-06-15 MX MXPA06014902A patent/MXPA06014902A/es active IP Right Grant
- 2005-06-15 BR BRPI0512404-2A patent/BRPI0512404A/pt not_active IP Right Cessation
- 2005-06-15 CA CA002571505A patent/CA2571505A1/en not_active Abandoned
- 2005-06-20 US US11/156,417 patent/US7253318B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2319213T3 (es) | 2009-05-05 |
WO2006000324A2 (en) | 2006-01-05 |
PL1761480T3 (pl) | 2009-07-31 |
KR100855618B1 (ko) | 2008-09-01 |
RU2006143570A (ru) | 2008-07-27 |
CN100554244C (zh) | 2009-10-28 |
EP1761480A2 (de) | 2007-03-14 |
EP1761480B1 (de) | 2009-02-18 |
US20050288367A1 (en) | 2005-12-29 |
AU2005256395B2 (en) | 2010-08-12 |
JP4427578B2 (ja) | 2010-03-10 |
RU2392267C2 (ru) | 2010-06-20 |
CA2571505A1 (en) | 2006-01-05 |
WO2006000324A3 (en) | 2006-03-02 |
CN1972903A (zh) | 2007-05-30 |
MXPA06014902A (es) | 2007-02-28 |
JP2008503514A (ja) | 2008-02-07 |
US7253318B2 (en) | 2007-08-07 |
BRPI0512404A (pt) | 2008-03-04 |
AU2005256395A1 (en) | 2006-01-05 |
DE602005012826D1 (de) | 2009-04-02 |
KR20070029753A (ko) | 2007-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200716121A (en) | Acetylenyl-pyrazolo-pyrimidine derivatives as mGluR2 antagonists | |
BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
DE60229530D1 (de) | Substituierte piperazine als modulatoren des melanocortinrezeptors | |
SE0403006D0 (sv) | New compounds | |
TW200635903A (en) | Therapeutic agents | |
MX2007010414A (es) | Derivados de piridin-2-carboxamida como antagonistas de mglur5. | |
IL189987A0 (en) | Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists | |
DE602005016261D1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
PT1902037E (pt) | 2,4-diamino-pirimidinas como inibidores de aurora | |
TNSN07349A1 (fr) | Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur | |
ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
TW200633986A (en) | Therapeutic agents | |
MX2008002061A (es) | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. | |
BR0314314A (pt) | Derivados do éter 4-pirrolidina-fenil-benzìlico | |
WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
MY169274A (en) | Fused, tricyclic sulfonamide inhibitors of gamma secretase | |
DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
NO20075477L (no) | Tetrahydro-pyridoazepin-8-one og beslektede forbindelser for behandling av schizofreni | |
TW200734324A (en) | Therapeutic agents | |
WO2003070728A3 (en) | Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders | |
MX2007003922A (es) | Nuevas propenonas ciclicas y aciclicas para tratar trastornos del sistema nervioso central. | |
MXPA05004273A (es) | Derivados de fenilalquil y piridilalquil piperazina. | |
SE0401763D0 (sv) | Compounds | |
WO2002036118A3 (en) | Heterocyclic derivatives useful as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1761480 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |